Compare DexCom, Inc. (DXCM) vs Lockheed Martin Corporation (LMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Lockheed Martin Corporation — how do they compare? DexCom, Inc. trades at $89.2 (market cap $33.79B), while Lockheed Martin Corporation trades at $597.2 (market cap $137.96B). The key difference: Lockheed Martin Corporation is far larger — about 4.1× DexCom, Inc.'s market cap, and Lockheed Martin Corporation pays a 2.31% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | LMT | |
|---|---|---|
Market Cap | $33.79B | $137.96B |
Sector | Health | Industrials |
52-Week High | $89.53 | $676.70 |
52-Week Low | $54.84 | $431.56 |
Enterprise Value | $33.24B | $154.71B |
Dividend Yield | — | 2.31% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Lockheed Martin Corporation
Lockheed Martin is the largest defense contractor globally and has dominated the Western market for high-end fighter aircraft since the F-35 program was awarded in 2001. Lockheed's largest segment is aeronautics, which is dominated by the massive F-35 program. Lockheed's remaining segments are rotary and mission systems, which is mainly the Sikorsky helicopter business.
Read more on LMT →
